5th Cancer Cachexia Conference
Bridging Molecular Advances to Clinical Care
Montreal, Canada, September 11-13, 2020

Preliminary Program

Updated: January 22, 2020         

Friday, September 11 | Saturday, September 12 | Sunday, September 13

The Conference venue is the Westin Montreal, 270 Saint-Antoine West, Montreal, Quebec

Friday, September 11, 2020

7:30 am Registration
Montreal Grand Ballroom Foyer - 11th floor
Note: All general sessions are held in the Montreal Grand Ballroom A-B-C
Clinical Advances in Assessments and Management in Cancer Cachexia
Chair: Dan Marks, MD, PhD – Oregon Health Sciences University, USA
Session A: Functional Outcome Measures for Cancer Cachexia
8:20 am Introductory Remarks
8:30 am Speaker 1 – TBA
(from requested abstracts)
9:00 am Speaker 2 – TBA
(from requested abstracts)
9:30 am Jorge Nieva, MD
University of Southern California, USA
Karnofsky revisited – Measuring performance status in the digital age

10:00 am Coffee Break
Montreal Grand Ballroom Foyer
Session B: Clinical Trial Results
10:30 am Marie Fallon, MD
University of Edinburgh, United Kingdom
Phenotyping of patients in clinical trials of cancer cachexia
11:00 am Tora Solheim, PhD
St. Olavs Hospital, Trondheim University Hospital, Norway
Why do we need a complex intervention in cancer cachexia?

11:30 am Jose Garcia, MD, PhD
University of Washington, USA
Androgens in cancer cachexia: A new purpose for an old drug

  Selected Short Talks
12:00 pm Short Talk 1
(selected from abstracts)
12:15 pm Short Talk 2
(selected from abstracts)

12:30 pm Lunch
Grab and go lunches will be provided
Session C: Conversations with Caregivers and Patients
Moderator 1: Thomas R. Jagoe, MD – McGill University, Canada
Moderator 2: Martin Kochanczyk, PhD – Luminex Corporation, USA
1:30–2:30 pm Program for Caregivers and Patients
Montreal Grand Ballroom A-B-C

2:30 pm Poster Set Up
Montreal Grand Ballroom D

Session 1: Introductory Remarks and Keynote Address
Chair: Josep Argiles, PhD – University of Barcelona, Spain
Montreal Grand Ballroom A-B-C
3:45 pm Introductions to the 5th Cancer Cachexia Conference
Denis Guttridge, PhD
Medical University of South Carolina, USA
4:00 pm Keynote Address
Annemie Schols, PhD
Maastricht University, Netherlands
Optimizing tumor treatment by new insights in cancer cachexia. No time to waste
5:00 pm Cutting Edge Science in Cancer Cachexia
Six speakers chosen from selected abstracts
5:00 pm Speaker 1 – TBA
5:05 pm Speaker 2 – TBA
5:10 pm Speaker 3 – TBA
5:15 pm Speaker 4 – TBA
5:20 pm Speaker 5 – TBA
5:25 pm Speaker 6 – TBA
5:30-7:30 pm Welcoming Reception
Fortifications Room - 9th floor
7:30 pm Poster Viewing
Montreal Grand Ballroom D

Dinner and evening on your own

Back to top ...

Saturday, September 12, 2020

6:30-8:30 am Breakfast
Montreal Grand Ballroom foyer
Note: All general sessions are held in the Montreal Grand Ballroom A-B-C
Session 2: Metabolic Dysfunction in Cancer Cachexia
Chair: TBA
8:30 am Norbert Perrimon, PhD
Harvard Medical School, USA
Insights on cachexia from a Drosophila model of organ wasting
9:00 am Stephan Herzig, PhD
Helmholtz Diabetes and Cancer Center, Germany
Organ-specific metabolic programs in cancer cachexia
  Selected Short Talks
9:30 am Short Talk 3
(selected from abstracts)
9:45 am Short Talk 4
(selected from abstracts)

10:30 am Coffee Break
Montreal Grand Ballroom foyer
Session 3: Mechanisms of Skeletal Muscle Wasting: Myofiber
Chair: Andrew Judge, PhD – University of Florida, USA
11:00 am Paul Gregorevic, PhD
University of Melbourne, Australia
Exploring and targeting new mechanisms implicated in muscle wasting associated with cancer cachexia
11:30 am Imed Gallouzi, PhD
McGill University, Canada
The iNOS/NO pathway drives mitochondrial dysfunction to promote cancer-induced muscle wasting
12:00 pm David Glass, MD
Regeneron, USA
The contribution of aging to cachexia

12:30 pm Lunch
Fortifications Room
1:45-3:45 pm Poster Viewing
Montreal Grand Ballroom D
Session 4: Nutrition Imbalance and Strategies in Cancer Cachexia
Chair: Richard Skipworth, MD – University of Edinburgh, United Kingdom
4:00 pm TBA
4:30 pm David Currow, MD
University of Technology Sydney, Australia
What have we learnt from clinical trials in cancer cachexia?”
  Selected Short Talks
5:00 pm Short Talk 5
(selected from abstracts)
5:15 pm Short Talk 6
(selected from abstracts)
5:30 pm End of program day
5:45 pm Cancer Cachexia Society Members Business Meeting

Back to top ...

Sunday, September 13, 2020

6:30-8:30 am Breakfast
Montreal Grand Ballroom foyer
Session 5: Identification of Biomarkers in Cancer Cachexia
Co-Chairs: Michael Espey, PhD & Christopher Hartshorn, PhD – National Institutes of Health, National Cancer Institute, USA
8:35 am Vera Mazurak, PhD
University of Alberta, Canada
Moving forward with human muscle evaluation: Proceed with caution
9:05 am David Thomas, MD
Broad Institute, USA
Cachexia biomarkers: Connecting lipid metabolites with aggressive drug-resistant cancers
  Selected Short Talks
9:35 am Short Talk 7
(selected from abstracts)
9:50 am Short Talk 8
(selected from abstracts)

10:05 am Coffee Break
Announcement of Poster Winners (3 basic science, 3 clinical science)
Montreal Grand Ballroom foyer
Session 6: Next Generation Researchers in Cancer Cachexia
Rishi Jain, MD – Fox Chase Cancer Center, USA
Cynthia Stretch, PhD – University of Calgary, Canada
10:30 am Speaker 1 – TBA
10:45 am Speaker 2 – TBA
11:00 am Speaker 3 – TBA
11:15 am Speaker 4 – TBA
11:30 am Speaker 5 – TBA
11:45 am Speaker 6 – TBA

12:00 pm Lunch
Fortifications Room
Session 7: Mechanisms of Muscle Wasting – Muscle Microenvironment
Chair: Yi-Ping Li, PhD – University of Texas Health Science Center, USA
1:30 pm Michael Rudnicki, PhD
University of Ottawa, Canada
Molecular regulation of stem cell function
2:00 pm Denis Guttridge, PhD
Medical University of South Carolina, USA
Insights into the interplay between the inflammatory cascade and muscle atrophy in cancer cachexia
2:30 pm Jerome Feige, PhD
Nestle, Switzerland
Crosstalk in the muscle stem cell niche during aging and cachexia

3:00 pm Coffee Break
Montreal Grand Ballroom foyer
Session 8: Therapy-Induced Muscle Dysfunction and Wasting
Chair: TBA 
3:30 pm Andrea Bonetto, PhD
Indiana University, USA
Mechanisms of chemotherapy-induced musculoskeletal complications
4:00 pm TBA
  Selected Short Talks
4:30 pm Short Talk 9
(selected from abstracts)
4:45 pm Short Talk 10
(selected from abstracts)
5:00 pm Closing Remarks

Back to top ...